Capricor Therapeutics, Inc. · 2 days ago
Shipping Associate
Capricor Therapeutics is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. They are seeking a Shipping Associate responsible for performing routine shipping and receiving activities to support commercial manufacturing, quality, and research operations.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Prepare, pack, and ship materials, components, and finished goods according to company SOPs and regulatory guidelines (e.g., GMP, GDP)
Verify accuracy of shipping documentation, including packing lists, invoices, and shipping labels
Coordinate with carriers and logistics partners to schedule pickups and track shipments
Receive incoming materials, inspect for damage, and verify against purchase orders
Collect and receive finished goods with flexible schedule
Maintain accurate inventory records in ERP system (e.g. NetSuite)
Ensure proper handling and storage of temperature-sensitive and hazardous materials
Assist in maintaining shipping supplies and equipment in good condition
Support compliance with DOT, IATA, and other applicable shipping regulations
Perform other duties as assigned to support Supply Chain operations
Qualification
Required
High school diploma or equivalent
1+ year experience in shipping/receiving or warehouse operations, preferably in a GMP-regulated environment
Familiarity with ERP systems and shipping software
Knowledge of domestic and international shipping regulations (DOT, IATA) is a plus
Ability to lift to 50 lbs and work in a fast-paced environment
Strong attention to detail and organizational skills
Company
Capricor Therapeutics, Inc.
Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives.
Funding
Current Stage
Public CompanyTotal Funding
$329.5MKey Investors
Nippon ShinyakuNational Institutes of HealthCalifornia Institute for Regenerative Medicine
2025-12-05Post Ipo Equity· $150M
2024-10-17Post Ipo Equity· $75M
2024-09-17Post Ipo Equity· $15M
Recent News
MarketScreener
2025-12-17
Genetic Engineering News
2025-12-09
Company data provided by crunchbase